Status:
COMPLETED
Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Kathmandu University School of Medical Sciences
Conditions:
Prediabetic State
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Background: The prediabetes population is a high risk group for developing diabetes and is also associated with a higher risk of micro- and macrovascular complications. Prevalence of prediabetes is al...
Eligibility Criteria
Inclusion
- Permanent residents of Dhulikhel municipality or Lalitpur Metropolitan City (Patan)
- Indian Diabetes Risk Score 60 or higher
- Prediabetes: glycated haemoglobin (HbA1c) 5.7-6.4 %
- Random blood sugar ≥ 140 to ≤ 250 mg/dl
Exclusion
- type 1 diabetes (self-report)
- Type 2 diabetes
- Under medication
- HbA1c criteria (≥ 6.5 %)
- Currently pregnant
- Critically ill patients
Key Trial Info
Start Date :
October 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
291 Patients enrolled
Trial Details
Trial ID
NCT04074148
Start Date
October 25 2019
End Date
September 30 2021
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kathmandu University School of Medical Science
Kathmandu, Nepal